AAAAAA
Results: 1-25/31
Authors:
CHESON BD
Citation: Bd. Cheson, NEW PROSPECTS IN THE TREATMENT OF INDOLENT LYMPHOMAS WITH PURINE ANALOGS, The cancer journal from Scientific American, 4, 1998, pp. 27-36
Authors:
CONLEY BA
SMILEY JK
CHESON BD
Citation: Ba. Conley et al., CLINICAL-TRIALS OF MULTIMODALITY APPROACHES FOR ADVANCED ESOPHAGEAL CANCER, Oncology, 12(6), 1998, pp. 856
Authors:
SMITH MA
CHESON BD
NELSON AP
Citation: Ma. Smith et al., CLINICAL-TRIALS REFERRAL RESOURCE - CHILDREN WITH BRAIN-TUMORS, Oncology, 12(3), 1998, pp. 393
Authors:
CHESON BD
NELSON AP
Citation: Bd. Cheson et Ap. Nelson, CLINICAL-TRIALS IN ADULT ACUTE-MYELOGENOUS-LEUKEMIA, Oncology, 12(2), 1998, pp. 224
Authors:
MCCABE M
BLATNER GL
CHESON BD
Citation: M. Mccabe et al., INTEGRATING ECONOMIC-ANALYSIS INTO COOPERATIVE GROUP TRIALS, Oncology, 12(11), 1998, pp. 1589
Authors:
CHESON BD
Citation: Bd. Cheson, CURRENT APPROACHES TO THERAPY FOR INDOLENT NON-HODGKINS-LYMPHOMA, Oncology, 12(10), 1998, pp. 25-34
Authors:
CHESON BD
SORENSEN JM
VENA DA
MONTELLO MJ
BARRET JA
DAMASIO E
TALLMAN M
ANNINO L
CONNERS J
COIFFIER B
LAURIA F
Citation: Bd. Cheson et al., TREATMENT OF HAIRY-CELL LEUKEMIA WITH 2-CHLORODEOXYADENOSINE VIA THE GROUP-C PROTOCOL MECHANISM OF THE NATIONAL-CANCER-INSTITUTE - A REPORTOF 979 PATIENTS, Journal of clinical oncology, 16(9), 1998, pp. 3007-3015
Authors:
CHESON BD
FRAME JN
VENA D
QUASHU N
SORENSEN JM
Citation: Bd. Cheson et al., TUMOR LYSIS SYNDROME - AN UNCOMMON COMPLICATION OF FLUDARABINE THERAPY OF CHRONIC LYMPHOCYTIC-LEUKEMIA, Journal of clinical oncology, 16(7), 1998, pp. 2313-2320
Authors:
WILSON WH
LITTLE R
PEARSON D
JAFFE ES
STEINBERG SM
CHESON BD
HUMPHREY R
KOHLER DR
ELWOOD P
Citation: Wh. Wilson et al., PHASE-II AND DOSE-ESCALATION WITH OR WITHOUT GRANULOCYTE-COLONY-STIMULATING FACTOR STUDY OF 9-AMINOCAMPTOTHECIN IN RELAPSED AND REFRACTORY LYMPHOMAS, Journal of clinical oncology, 16(7), 1998, pp. 2345-2351
Authors:
CHESON BD
Citation: Bd. Cheson, STANDARD AND LOW-DOSE CHEMOTHERAPY FOR THE TREATMENT OF MYELODYSPLASTIC SYNDROMES, Leukemia research, 22, 1998, pp. 17-21
Authors:
ZWIEBEL JA
CHESON BD
Citation: Ja. Zwiebel et Bd. Cheson, CHRONIC LYMPHOCYTIC-LEUKEMIA - STAGING AND PROGNOSTIC FACTORS, Seminars in oncology, 25(1), 1998, pp. 42-59
Authors:
CHESON BD
Citation: Bd. Cheson, CHRONIC LYMPHOCYTIC-LEUKEMIA IN THE PURINE ANALOG ERA - NEW INSIGHTS AND CHALLENGES, Seminars in hematology, 35(3), 1998, pp. 1-2
Authors:
CHESON BD
Citation: Bd. Cheson, THERAPY FOR PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC-LEUKEMIA - A REEVALUATION, Seminars in hematology, 35(3), 1998, pp. 14-21
Authors:
ARBUCK SG
SORENSEN JM
CHRISTIAN MC
HO P
PLUDA JM
CHESON BD
Citation: Sg. Arbuck et al., NEW DRUGS IN NON-HODGKINS-LYMPHOMA, Annals of oncology, 8, 1997, pp. 119-128
Authors:
SORENSEN JM
VENA DA
FALLAVOLLITA A
CHUN HG
CHESON BD
Citation: Jm. Sorensen et al., TREATMENT OF REFRACTORY CHRONIC LYMPHOCYTIC-LEUKEMIA WITH FLUDARABINEPHOSPHATE VIA THE GROUP-C PROTOCOL MECHANISM OF THE NATIONAL-CANCER-INSTITUTE - 5-YEAR FOLLOW-UP REPORT, Journal of clinical oncology, 15(2), 1997, pp. 458-465
Authors:
GRILLOLOPEZ AJ
HORNING S
CHESON BD
PETERSON B
COIFFIER B
HAGENBEEK A
HIDDEMAN W
MARCUS R
LISTER TA
Citation: Aj. Grillolopez et al., DEVELOPMENT OF RESPONSE CRITERIA (RC) FOR LOW-GRADE OR FOLLICULAR LYMPHOMAS (LG F NHL) AND APPLICATION IN A 166 PATIENT STUDY/, Experimental hematology, 25(8), 1997, pp. 17-17
Authors:
CHESON BD
Citation: Bd. Cheson, TRIALS AND TRIBULATIONS, Leukemia research, 21(1), 1997, pp. 1-1
Authors:
FLINN IW
KOPECKY KJ
FOUCAR MK
HEAD D
BENNETT JM
HUTCHISON RE
CORBETT WEN
CASSILETH PA
HABERMANN T
GOLOMB H
RAI K
EISENHAUER E
APPELBAUM FR
CHESON BD
GREVER M
Citation: Iw. Flinn et al., LONG-TERM RESULTS IN HAIRY-CELL LEUKEMIA (HCL) TREATED WITH PENTOSTATIN, Blood, 90(10), 1997, pp. 2575-2575
Authors:
CHESON BD
Citation: Bd. Cheson, PERSPECTIVES ON PURINE ANALOGS, HEM CELL TH, 38, 1996, pp. 109-116
Authors:
CHESON BD
Citation: Bd. Cheson, ENNUI OR NOT ENNUI, THAT IS THE QUESTION, Annals of oncology, 7(8), 1996, pp. 767-769
Authors:
CHESON BD
Citation: Bd. Cheson, INFECTIOUS AND IMMUNOSUPPRESSIVE COMPLICATIONS OF PURINE ANALOG THERAPY, Journal of clinical oncology, 13(9), 1995, pp. 2431-2448
Authors:
GREVER M
KOPECKY K
FOUCAR MK
HEAD D
BENNETT JM
HUTCHISON RE
CORBETT WEN
CASSILETH PA
HABERMANN T
GOLOMB H
RAI K
EISENHAUER E
APPELBAUM F
CHESON BD
Citation: M. Grever et al., RANDOMIZED COMPARISON OF PENTOSTATIN VERSUS INTERFERON ALFA-2A IN PREVIOUSLY UNTREATED PATIENTS WITH HAIRY-CELL LEUKEMIA - AN INTERGROUP STUDY, Journal of clinical oncology, 13(4), 1995, pp. 974-982
Authors:
WILSON WH
CHABNER BA
BRYANT G
BATES S
FOJO A
REGIS J
JAFFE ES
STEINBERG SM
GOLDSPIEL BR
CHESON BD
WITTES RE
Citation: Wh. Wilson et al., PHASE-II STUDY OF PACLITAXEL IN RELAPSED NON-HODGKINS-LYMPHOMAS, Journal of clinical oncology, 13(2), 1995, pp. 381-386
Authors:
CHESON BD
VENA DA
FOSS FM
SORENSEN JM
Citation: Bd. Cheson et al., NEUROTOXICITY OF PURINE ANALOGS - A REVIEW, Journal of clinical oncology, 12(10), 1994, pp. 2216-2228
Authors:
SILBERMAN G
CROSSE MG
PETERSON EA
WESTON RC
HOROWITZ MM
APPELBAUM FR
CHESON BD
Citation: G. Silberman et al., AVAILABILITY AND APPROPRIATENESS OF ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA IN 10 COUNTRIES, The New England journal of medicine, 331(16), 1994, pp. 1063-1067